LOREGIAN, ARIANNA
LOREGIAN, ARIANNA
Dipartimento di Medicina Molecolare - DMM
Antiviral strategies against influenza virus: an update on approved and innovative therapeutic approaches
2025 Bonomini, A.; Mercorelli, B.; Loregian, A.
Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity
2024 Desantis, Jenny; Bazzacco, Alessandro; Eleuteri, Michela; Tuci, Sara; Bianconi, Elisa; Macchiarulo, Antonio; Mercorelli, Beatrice; Loregian, Arianna; Goracci, Laura
Elaborate Structural Modifications Yielding Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Potent Neuraminidase Inhibitors with Significantly Improved Broad-Spectrum Antiresistance Profiles
2024 Zhang, Jiwei; Jia, Ruifang; Jia, Huinan; Li, Ping; Jiang, Yuanmin; Bonomini, Anna; Bertagnin, Chiara; Xu, Qiaojie; Tan, Zhou; Ma, Xiuli; Loregian, Arianna; Huang, Bing; Liu, Xinyong; Zhan, Peng
Exploring a New Generation of Pyrimidine and Pyridine Derivatives as Anti-Influenza Agents Targeting the Polymerase PA–PB1 Subunits Interaction
2024 Giacchello, I.; Cianciusi, A.; Bertagnin, C.; Bonomini, A.; Francesconi, V.; Mori, M.; Carbone, A.; Musumeci, F.; Loregian, A.; Schenone, S.
Human neural progenitor cell models to study the antiviral effects and neuroprotective potential of approved and investigational human cytomegalovirus inhibitors
2024 Trevisan, M.; Pianezzola, A.; Onorati, M.; Apolloni, L.; Pistello, M.; Arav-Boger, R.; Palu, G.; Mercorelli, B.; Loregian, A.
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization
2024 Bonomini, A.; Felicetti, T.; Pacetti, M.; Bertagnin, C.; Coletti, A.; Giammarino, F.; De Angelis, M.; Poggialini, F.; Macchiarulo, A.; Sabatini, S.; Mercorelli, B.; Nencioni, L.; Vicenti, I.; Dreassi, E.; Cecchetti, V.; Tabarrini, O.; Loregian, A.; Massari, S.
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines
2024 Pacetti, Martina; Pismataro, Maria Chiara; Felicetti, Tommaso; Giammarino, Federica; Bonomini, Anna; Tiecco, Matteo; Bertagnin, Chiara; Barreca, Maria Letizia; Germani, Raimondo; Cecchetti, Violetta; Vicenti, Ilaria; Tabarrini, Oriana; Zazzi, Maurizio; Loregian, Arianna; Massari, Serena
Synergistic activity of an RNA polymerase PA-PB1 interaction inhibitor with oseltamivir against human and avian influenza viruses in cell culture and in ovo
2024 Bonomini, A.; Zhang, J.; Ju, H.; Zago, A.; Pacetti, M.; Tabarrini, O.; Massari, S.; Liu, X.; Mercorelli, B.; Zhan, P.; Loregian, A.
A novel N-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation
2023 Zhang, J.; Liu, C.; Jia, R.; Zhang, X.; Zhang, J.; Bertagnin, C.; Bonomini, A.; Guizzo, L.; Jiang, Y.; Jia, H.; Jia, S.; Ma, X.; Loregian, A.; Huang, B.; Zhan, P.; Liu, X.
A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells
2023 Bertagnin, C.; Messa, L.; Pavan, M.; Celegato, M.; Sturlese, M.; Mercorelli, B.; Moro, S.; Loregian, A.
Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability
2023 Gao, S.; Song, L.; Sylvester, K.; Mercorelli, B.; Loregian, A.; Toth, K.; Weisse, R. H.; Useini, A.; Strater, N.; Yang, M.; Ye, B.; Tollefson, A. E.; Muller, C. E.; Liu, X.; Zhan, P.
Discovery of N-substituted oseltamivir derivatives as novel neuraminidase inhibitors with improved drug resistance profiles and favorable drug-like properties
2023 Jia, R.; Zhang, J.; Shi, F.; Bonomini, A.; Lucca, C.; Bertagnin, C.; Zhang, J.; Liu, C.; Jia, H.; Jiang, Y.; Ma, X.; Loregian, A.; Huang, B.; Zhan, P.; Liu, X.
IN VITRO ANTIVIRAL ACTIVITY OF EPIGALLOCATECHIN GALLATE AGAINST RABIES VIRUS
2023 Pasqual, D.; Loregian, A.; Salata, C.
Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy In Vivo
2023 Celegato, M.; Sturlese, M.; Costa, V. V.; Trevisan, M.; Dias, A. S. L.; Passos, I. B. S.; Queiroz-Junior, C. M.; Messa, L.; Favaro, A.; Moro, S.; Teixeira, M. M.; Loregian, A.; Mercorelli, B.
Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins
2022 Hou, L.; Zhang, Y.; Ju, H.; Cherukupalli, S.; Jia, R.; Zhang, J.; Huang, B.; Loregian, A.; Liu, X.; Zhan, P.
Discovery of Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant
2022 Jia, Ruifang; Zhang, Jiwei; Zhang, Jian; Bertagnin, Chiara; Bonomini, Anna; Guizzo, Laura; Gao, Zhen; Ji, Xiangkai; Li, Zhuo; Liu, Chuanfeng; Ju, Han; Ma, Xiuli; Loregian, Arianna; Huang, Bing; Zhan, Peng; Liu, Xinyong
Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization
2022 Mercorelli, Beatrice; Desantis, Jenny; Celegato, Marta; Bazzacco, Alessandro; Siragusa, Lydia; Benedetti, Paolo; Eleuteri, Michela; Croci, Federico; Cruciani, Gabriele; Goracci, Laura; Loregian, Arianna
HPV-induced cancers: preclinical therapeutic advancements
2022 Messa, L.; Loregian, A.
Iterative Optimization and Structure-Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors via Targeting 150-Cavity
2022 Ju, Han; Hou, Lingxin; Zhao, Fabao; Zhang, Ying; Jia, Ruifang; Guizzo, Laura; Bonomini, Anna; Zhang, Jiwei; Gao, Zhen; Liang, Ruipeng; Bertagnin, Chiara; Kong, Xiujie; Ma, Xiuli; Kang, Dongwei; Loregian, Arianna; Huang, Bing; Liu, Xinyong; Zhan, Peng
Targeted disruption of e6/p53 binding exerts broad activity and synergism with paclitaxel and topotecan against hpv-transformed cancer cells
2022 Celegato, M.; Messa, L.; Bertagnin, C.; Mercorelli, B.; Loregian, A.